Skip to main content
Erschienen in: Current HIV/AIDS Reports 2/2014

01.06.2014 | The Global Epidemic (S Vermund, Section Editor)

The HIV Epidemic in Southern Africa – Is an AIDS-Free Generation Possible?

verfasst von: Wim Delva, Quarraisha Abdool Karim

Erschienen in: Current HIV/AIDS Reports | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Southern Africa, home to about 20 % of the global burden of infection continues to experience high rates of new HIV infection despite substantial programmatic scale-up of treatment and prevention interventions. While several countries in the region have had substantial reductions in HIV infection, almost half a million new infections occurred in this region in 2012. Sexual transmission remains the dominant mode of transmission. A recent national household survey in Swaziland revealed an HIV prevalence of 14.3 % among 18–19 year old girls, compared to 0.8 % among their male peers. Expanded ART programmes in Southern Africa have resulted in dramatically decreased HIV incidence and HIV mortality rates. In South Africa alone, it is estimated that more than 2.1 million of the 6.1 million HIV-positive people were receiving ART by the end of 2012, and that this resulted in more than 2.7 million life-years saved, and hundreds of thousands of HIV infections averted. Biological, behavioural and structural factors all contribute to the ongoing high rates of new HIV infection; however, as the epidemic matures and mortality is reduced from increased ART coverage, epidemiological trends become hard to quantify. What is clear is that a key driver of the Southern African epidemic is the high incidence rate of infection in young women, a vulnerable population with limited prevention options. Moreover, whilst ongoing trials of combination prevention, microbicides and behavioural economics hold promise for further epidemic control, an AIDS-free generation will not be realised unless incident infections in key populations are reduced.
Fußnoten
1
Swaziland, Lesotho, Botswana, South Africa, Zimbabwe, Namibia, Zambia, Mozambique, Angola and Malawi
 
2
According to the President’s Emergency Plan for AIDS Relief (PEPFAR), an AIDS-free generation entails that first, no one will be born with the virus; second, that as people get older, they will be at a far lower risk of becoming infected than they are today; and third, that if they do acquire HIV, they will get treatment that keeps them healthy and prevents them from transmitting the virus to others.
 
Literatur
2.
Zurück zum Zitat Mayosi BM, Lawn JE, van Niekerk A, et al. Health in South Africa: changes and challenges since 2009. Lancet. 2012;380(9858):2029–43.PubMedCrossRef Mayosi BM, Lawn JE, van Niekerk A, et al. Health in South Africa: changes and challenges since 2009. Lancet. 2012;380(9858):2029–43.PubMedCrossRef
4.••
Zurück zum Zitat Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Describes the results of the seminal study which demonstrated a significant reduction of HIV transmission in HIV+ patients on antiretroviral therapy.PubMedCentralPubMedCrossRef Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Describes the results of the seminal study which demonstrated a significant reduction of HIV transmission in HIV+ patients on antiretroviral therapy.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Abdool Karim SS, Abdool Karim Q. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet. 2011;378(9809):e23–5.PubMedCentralCrossRef Abdool Karim SS, Abdool Karim Q. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet. 2011;378(9809):e23–5.PubMedCentralCrossRef
6.
Zurück zum Zitat Fauci AS, Folkers GK, Dieffenbach CW. HIV-AIDS: much accomplished, much to do. Nat Immunol. 2013;14(11):1104–7.PubMedCrossRef Fauci AS, Folkers GK, Dieffenbach CW. HIV-AIDS: much accomplished, much to do. Nat Immunol. 2013;14(11):1104–7.PubMedCrossRef
8.•
Zurück zum Zitat Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS. 2013;27(3):447–58. An important modelling analysis which highlights the potential impact of treatment as prevention on epidemiologic trajectories.PubMedCrossRef Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS. 2013;27(3):447–58. An important modelling analysis which highlights the potential impact of treatment as prevention on epidemiologic trajectories.PubMedCrossRef
9.
Zurück zum Zitat Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374(9693):921–33.PubMedCentralPubMedCrossRef Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374(9693):921–33.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Goodreau SM, Cassels S, Kasprzyk D, Montano DE, Greek A, Morris M. Concurrent partnerships, acute infection and HIV epidemic dynamics among young adults in Zimbabwe. AIDS Behav. 2012;16(2):312–22.PubMedCentralPubMedCrossRef Goodreau SM, Cassels S, Kasprzyk D, Montano DE, Greek A, Morris M. Concurrent partnerships, acute infection and HIV epidemic dynamics among young adults in Zimbabwe. AIDS Behav. 2012;16(2):312–22.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Robinson K, Cohen T, Colijn C. The dynamics of sexual contact networks: effects on disease spread and control. Theor Popul Biol. 2012;81(2):89–96.PubMedCentralPubMedCrossRef Robinson K, Cohen T, Colijn C. The dynamics of sexual contact networks: effects on disease spread and control. Theor Popul Biol. 2012;81(2):89–96.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Hool A, Leventhal GE, Bonhoeffer S. Virus-induced target cell activation reconciles set-point viral load heritability and within-host evolution. Epidemics. 2013;5(4):174–80.PubMedCrossRef Hool A, Leventhal GE, Bonhoeffer S. Virus-induced target cell activation reconciles set-point viral load heritability and within-host evolution. Epidemics. 2013;5(4):174–80.PubMedCrossRef
15.
Zurück zum Zitat Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, et al. Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission. PLoS One. 2012;7(11):e51192.PubMedCentralPubMedCrossRef Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, et al. Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission. PLoS One. 2012;7(11):e51192.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Gouws E, Cuchi P, International Collaboration on Estimating HIV Incidence by Modes of Transmission. Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect. 2012;88 Suppl 2:i76–85. Gouws E, Cuchi P, International Collaboration on Estimating HIV Incidence by Modes of Transmission. Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect. 2012;88 Suppl 2:i76–85.
17.
Zurück zum Zitat Asher AK, Hahn JA, Couture MC, Maher K, Page K. People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013;24(6):e35–44.PubMedCentralPubMedCrossRef Asher AK, Hahn JA, Couture MC, Maher K, Page K. People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013;24(6):e35–44.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Pruss-Ustun A, Wolf J, Driscoll T, Degenhardt L, Neira M, Calleja JM. HIV due to female sex work: regional and global estimates. PLoS One. 2013;8(5):e63476.PubMedCentralPubMedCrossRef Pruss-Ustun A, Wolf J, Driscoll T, Degenhardt L, Neira M, Calleja JM. HIV due to female sex work: regional and global estimates. PLoS One. 2013;8(5):e63476.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Tanser F, de Oliveira T, Maheu-Giroux M, Barnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS. 2014;9(2):115–25. Tanser F, de Oliveira T, Maheu-Giroux M, Barnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS. 2014;9(2):115–25.
20.
Zurück zum Zitat Chersich MF, Luchters S, Ntaganira I, Gerbase A, Lo YR, Scorgie F, et al. Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services. J Int AIDS Soc. 2013;16(1):17980.PubMedCentralPubMedCrossRef Chersich MF, Luchters S, Ntaganira I, Gerbase A, Lo YR, Scorgie F, et al. Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services. J Int AIDS Soc. 2013;16(1):17980.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Makofane K, Gueboguo C, Lyons D, Sandfort T. Men who have sex with men inadequately addressed in African AIDS National Strategic Plans. Glob Public Health. 2013;8(2):129–43.21.PubMedCentralPubMedCrossRef Makofane K, Gueboguo C, Lyons D, Sandfort T. Men who have sex with men inadequately addressed in African AIDS National Strategic Plans. Glob Public Health. 2013;8(2):129–43.21.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Ngugi EN, Roth E, Mastin T, Nderitu MG, Yasmin S. Female sex workers in Africa: epidemiology overview, data gaps, ways forward. SAHARA J. 2012;9(3):148–53.PubMedCrossRef Ngugi EN, Roth E, Mastin T, Nderitu MG, Yasmin S. Female sex workers in Africa: epidemiology overview, data gaps, ways forward. SAHARA J. 2012;9(3):148–53.PubMedCrossRef
23.
Zurück zum Zitat Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, et al. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One. 2013;8(10):e77101.PubMedCentralPubMedCrossRef Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, et al. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One. 2013;8(10):e77101.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat van Loggerenberg F, Dieter AA, Sobieszczyk ME, Werner L, Grobler A, Mlisana K, et al. HIV prevention in high-risk women in South Africa: condom use and the need for change. PLoS One. 2012;7(2):e30669.PubMedCentralPubMedCrossRef van Loggerenberg F, Dieter AA, Sobieszczyk ME, Werner L, Grobler A, Mlisana K, et al. HIV prevention in high-risk women in South Africa: condom use and the need for change. PLoS One. 2012;7(2):e30669.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Conn C. Young African women must have empowering and receptive social environments for HIV prevention. AIDS Care. 2013;25(3):273–80.PubMed Conn C. Young African women must have empowering and receptive social environments for HIV prevention. AIDS Care. 2013;25(3):273–80.PubMed
26.
Zurück zum Zitat Andersson N, Cockcroft A. Choice-disability and HIV infection: a cross sectional study of HIV status in Botswana, Namibia and Swaziland. AIDS Behav. 2012;16(1):189–98.PubMedCentralPubMedCrossRef Andersson N, Cockcroft A. Choice-disability and HIV infection: a cross sectional study of HIV status in Botswana, Namibia and Swaziland. AIDS Behav. 2012;16(1):189–98.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Yi TJ, Shannon B, Prodger J, McKinnon L, Kaul R. Genital immunology and HIV susceptibility in young women. Am J Reprod Immunol. 2013;69 Suppl 1:74–9.PubMedCrossRef Yi TJ, Shannon B, Prodger J, McKinnon L, Kaul R. Genital immunology and HIV susceptibility in young women. Am J Reprod Immunol. 2013;69 Suppl 1:74–9.PubMedCrossRef
28.
Zurück zum Zitat d’Albis H, Augeraud-Veron E, Djemai E, Ducrot A. The dispersion of age differences between partners and the asymptotic dynamics of the HIV epidemic. J Biol Dyn. 2012;6(2):695–717.PubMedCrossRef d’Albis H, Augeraud-Veron E, Djemai E, Ducrot A. The dispersion of age differences between partners and the asymptotic dynamics of the HIV epidemic. J Biol Dyn. 2012;6(2):695–717.PubMedCrossRef
29.
Zurück zum Zitat Bershteyn A, Klein DJ, Eckhoff PA. Age-dependent partnering and the HIV transmission chain: a microsimulation analysis. J R Soc Interface. 2013;10(88):20130613.PubMedCentralPubMedCrossRef Bershteyn A, Klein DJ, Eckhoff PA. Age-dependent partnering and the HIV transmission chain: a microsimulation analysis. J R Soc Interface. 2013;10(88):20130613.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Beauclair R, Kassanjee R, Temmerman M, Welte A, Delva W. Age-disparate relationships and implications for STI transmission among young adults in Cape Town, South Africa. Eur J Contracept Reprod Health Care. 2012;17(1):30–9.PubMedCrossRef Beauclair R, Kassanjee R, Temmerman M, Welte A, Delva W. Age-disparate relationships and implications for STI transmission among young adults in Cape Town, South Africa. Eur J Contracept Reprod Health Care. 2012;17(1):30–9.PubMedCrossRef
31.
Zurück zum Zitat Zembe YZ, Townsend L, Thorson A, Ekstrom AM. “Money talks, bullshit walks” interrogating notions of consumption and survival sex among young women engaging in transactional sex in post-apartheid South Africa: a qualitative enquiry. Glob Health. 2013;9:28.CrossRef Zembe YZ, Townsend L, Thorson A, Ekstrom AM. “Money talks, bullshit walks” interrogating notions of consumption and survival sex among young women engaging in transactional sex in post-apartheid South Africa: a qualitative enquiry. Glob Health. 2013;9:28.CrossRef
32.
Zurück zum Zitat Beauclair R, Delva W. Is younger really safer? A qualitative study of perceived risks and benefits of age-disparate relationships among women in Cape Town, South Africa. PLoS One 2013;8(11):e81748. Beauclair R, Delva W. Is younger really safer? A qualitative study of perceived risks and benefits of age-disparate relationships among women in Cape Town, South Africa. PLoS One 2013;8(11):e81748.
33.
Zurück zum Zitat Cluver L, Boyes M, Orkin M, Pantelic M, Molwena T, Sherr L. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case–control study. Lancet Glob Health. 2013;1(6):e362–70.CrossRef Cluver L, Boyes M, Orkin M, Pantelic M, Molwena T, Sherr L. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case–control study. Lancet Glob Health. 2013;1(6):e362–70.CrossRef
34.
Zurück zum Zitat Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379(9823):1320–9.PubMedCrossRef Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379(9823):1320–9.PubMedCrossRef
35.••
Zurück zum Zitat Abdool Karim Q, Kharsany ABM, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, et al. HIV Incidence in Young Girls in KwaZulu-Natal, South Africa-Public Health Imperative for Their inclusion in HIV Biomedical Intervention Trials. AIDS Behav. 2012;16(7):1870–6. PMC3460144 This survey highlights the magnitude of the burden of HIV in adolescent girls.PubMedCrossRef Abdool Karim Q, Kharsany ABM, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, et al. HIV Incidence in Young Girls in KwaZulu-Natal, South Africa-Public Health Imperative for Their inclusion in HIV Biomedical Intervention Trials. AIDS Behav. 2012;16(7):1870–6. PMC3460144 This survey highlights the magnitude of the burden of HIV in adolescent girls.PubMedCrossRef
36.
Zurück zum Zitat Kharsany AB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool Karim SS, et al. HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services. BMC Public Health. 2012;12:231. PMC3359203.PubMedCentralPubMedCrossRef Kharsany AB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool Karim SS, et al. HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services. BMC Public Health. 2012;12:231. PMC3359203.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat April MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, et al. The Survival Benefits of Antiretroviral Therapy in South Africa. J Infect Dis. 2014;209(4):491–9. April MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, et al. The Survival Benefits of Antiretroviral Therapy in South Africa. J Infect Dis. 2014;209(4):491–9.
38.
Zurück zum Zitat Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245.PubMedCentralPubMedCrossRef Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–5.PubMedCrossRef Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–5.PubMedCrossRef
40.•
Zurück zum Zitat Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71. This study highlights the potential population-level impact of ART scale-up.PubMedCrossRef Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71. This study highlights the potential population-level impact of ART scale-up.PubMedCrossRef
41.
Zurück zum Zitat Zaidi J, Grapsa E, Tanser F, Newell ML, Barnighausen T. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS. 2013;27(14):2301–5.PubMedCrossRef Zaidi J, Grapsa E, Tanser F, Newell ML, Barnighausen T. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS. 2013;27(14):2301–5.PubMedCrossRef
42.
Zurück zum Zitat Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013;10(4):e1001418.PubMedCentralPubMedCrossRef Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013;10(4):e1001418.PubMedCentralPubMedCrossRef
43.•
Zurück zum Zitat Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, et al. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013;369(18):1715–25. This study highlights the economic arguments for immediate initiation of ART in HIV+ patients.PubMedCentralPubMedCrossRef Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, et al. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013;369(18):1715–25. This study highlights the economic arguments for immediate initiation of ART in HIV+ patients.PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Hontelez JA, Lurie MN, Barnighausen T, Bakker R, Baltussen R, Tanser F, et al. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med. 2013;10(10):e1001534.PubMedCentralPubMedCrossRef Hontelez JA, Lurie MN, Barnighausen T, Bakker R, Baltussen R, Tanser F, et al. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med. 2013;10(10):e1001534.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Barnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A. 2012;109(52):21271–6.PubMedCentralPubMedCrossRef Barnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A. 2012;109(52):21271–6.PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, et al. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050. PLoS One. 2012;7(2):e30216.PubMedCentralPubMedCrossRef Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, et al. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050. PLoS One. 2012;7(2):e30216.PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382(9903):1515–24.PubMedCrossRef Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382(9903):1515–24.PubMedCrossRef
48.
Zurück zum Zitat Delva W, Fleming Y, Chingandu L. When to start ART in Africa–primarily guided by RCTs or patient autonomy? J Int AIDS Soc. 2013;16:18756.PubMedCentralPubMed Delva W, Fleming Y, Chingandu L. When to start ART in Africa–primarily guided by RCTs or patient autonomy? J Int AIDS Soc. 2013;16:18756.PubMedCentralPubMed
49.
Zurück zum Zitat Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, et al. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS. 2013;27(7):1159–65.PubMedCrossRef Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, et al. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS. 2013;27(7):1159–65.PubMedCrossRef
50.
Zurück zum Zitat Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, et al. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. J Acquir Immune Defic Syndr. 2013;62(5):555–61.PubMedCentralPubMedCrossRef Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, et al. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. J Acquir Immune Defic Syndr. 2013;62(5):555–61.PubMedCentralPubMedCrossRef
51.
Zurück zum Zitat Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013;368(3):218–30.PubMedCentralPubMedCrossRef Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013;368(3):218–30.PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc. 2013;16:18757.PubMedCentralPubMedCrossRef Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc. 2013;16:18757.PubMedCentralPubMedCrossRef
53.
Zurück zum Zitat Sibbald B. HIV prevention: new pilots for beleaguered Swaziland. Lancet. 2013;381(9861):103–4.PubMedCrossRef Sibbald B. HIV prevention: new pilots for beleaguered Swaziland. Lancet. 2013;381(9861):103–4.PubMedCrossRef
54.
Zurück zum Zitat Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, Shapiro R, et al. HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the “test-and-treat” approach to reduce HIV transmission. PLoS One. 2010;5(4):e10148.PubMedCentralPubMedCrossRef Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, Shapiro R, et al. HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the “test-and-treat” approach to reduce HIV transmission. PLoS One. 2010;5(4):e10148.PubMedCentralPubMedCrossRef
55.
Zurück zum Zitat Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART) Study Team. HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15(1):57.PubMedCentralPubMedCrossRef Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART) Study Team. HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15(1):57.PubMedCentralPubMedCrossRef
56.
Zurück zum Zitat Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials 2013;14:230. Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials 2013;14:230.
57.
Zurück zum Zitat Chen Y. Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009–2012) in an era of treatment as prevention. Curr HIV/AIDS Rep. 2013;10(1):79–88.PubMedCentralPubMedCrossRef Chen Y. Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009–2012) in an era of treatment as prevention. Curr HIV/AIDS Rep. 2013;10(1):79–88.PubMedCentralPubMedCrossRef
58.
Zurück zum Zitat McGrath N, Eaton JW, Barnighausen TW, Tanser F, Newell ML. Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era. AIDS. 2013;27(15):2461–70.PubMedCentralPubMedCrossRef McGrath N, Eaton JW, Barnighausen TW, Tanser F, Newell ML. Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era. AIDS. 2013;27(15):2461–70.PubMedCentralPubMedCrossRef
59.
Zurück zum Zitat Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect. 2012;88 Suppl 2:i11–6.PubMedCentralPubMedCrossRef Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect. 2012;88 Suppl 2:i11–6.PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8(2):e1000414.PubMedCentralPubMedCrossRef Halperin DT, Mugurungi O, Hallett TB, Muchini B, Campbell B, Magure T, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8(2):e1000414.PubMedCentralPubMedCrossRef
61.
Zurück zum Zitat Johnson LF, Hallett TB, Rehle TM, Dorrington RE. The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface. 2012;9(72):1544–54.PubMedCentralPubMedCrossRef Johnson LF, Hallett TB, Rehle TM, Dorrington RE. The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface. 2012;9(72):1544–54.PubMedCentralPubMedCrossRef
62.
Zurück zum Zitat Langhaug L, Buzdugan R, Copas A, Dirawo J, Benedict C, Mundida O, et al. Change over time (2007–2009) in HIV preventive behaviours, evidence from two serial population-based surveys in rural Zimbabwe. Trop Med Int Health. 2012;17(7):827–35.PubMedCrossRef Langhaug L, Buzdugan R, Copas A, Dirawo J, Benedict C, Mundida O, et al. Change over time (2007–2009) in HIV preventive behaviours, evidence from two serial population-based surveys in rural Zimbabwe. Trop Med Int Health. 2012;17(7):827–35.PubMedCrossRef
63.
Zurück zum Zitat Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Pillay-van-Wyk V, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? Cape Town: Human Sciences Research Council; 2009. Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Pillay-van-Wyk V, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? Cape Town: Human Sciences Research Council; 2009.
64.
Zurück zum Zitat Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART) study team. HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model. PLoS One. 2014;9(1):e84511.PubMedCentralPubMedCrossRef Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART) study team. HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model. PLoS One. 2014;9(1):e84511.PubMedCentralPubMedCrossRef
65.
Zurück zum Zitat Abdool Karim Q, Abdool Karim SS, Frohlich JA, Baxter C, Mansoor L, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, Baxter C, Mansoor L, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef
66.
Zurück zum Zitat Karim SS, Karim Q. Effectiveness and safety of vaginal microbicide 1 % tenofovir gel for prevention of HIV infection in women. Abstract TUSS0204 presented at the XVIII International AIDS Conference; July 18–23, 2010; Vienna, Austria Karim SS, Karim Q. Effectiveness and safety of vaginal microbicide 1 % tenofovir gel for prevention of HIV infection in women. Abstract TUSS0204 presented at the XVIII International AIDS Conference; July 18–23, 2010; Vienna, Austria
67.
Zurück zum Zitat Mossong J, Grapsa E, Tanser F, Barnighausen T, Newell ML. Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS. 2013;27(15):2471–9.PubMedCentralPubMedCrossRef Mossong J, Grapsa E, Tanser F, Barnighausen T, Newell ML. Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS. 2013;27(15):2471–9.PubMedCentralPubMedCrossRef
68.
Zurück zum Zitat Mahiane GS, Ouifki R, Brand H, Delva W, Welte A. A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation. PLoS One. 2012;7(9):e44377.PubMedCentralPubMedCrossRef Mahiane GS, Ouifki R, Brand H, Delva W, Welte A. A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation. PLoS One. 2012;7(9):e44377.PubMedCentralPubMedCrossRef
69.•
Zurück zum Zitat Kassanjee R, McWalter TA, Barnighausen T, Welte A. A new general biomarker-based incidence estimator. Epidemiology. 2012;23(5):721–8. Describes exciting new biomarker-based approach for evaluating HIV incidence which is needed to accurately monitor epidemiological trends of HIV.PubMedCentralPubMedCrossRef Kassanjee R, McWalter TA, Barnighausen T, Welte A. A new general biomarker-based incidence estimator. Epidemiology. 2012;23(5):721–8. Describes exciting new biomarker-based approach for evaluating HIV incidence which is needed to accurately monitor epidemiological trends of HIV.PubMedCentralPubMedCrossRef
70.
Zurück zum Zitat Laeyendecker O, Kulich M, Donnell D, Komarek A, Omelka M, Mullis CE, et al. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One. 2013;8(11):e78818.PubMedCentralPubMedCrossRef Laeyendecker O, Kulich M, Donnell D, Komarek A, Omelka M, Mullis CE, et al. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One. 2013;8(11):e78818.PubMedCentralPubMedCrossRef
Metadaten
Titel
The HIV Epidemic in Southern Africa – Is an AIDS-Free Generation Possible?
verfasst von
Wim Delva
Quarraisha Abdool Karim
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 2/2014
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-014-0205-0

Weitere Artikel der Ausgabe 2/2014

Current HIV/AIDS Reports 2/2014 Zur Ausgabe

The Global Epidemic (S Vermund, Section Editor)

Changing Patterns of HIV Epidemic in 30 Years in East Asia

The Global Epidemic (S Vermund, Section Editor)

The HIV Epidemic in Eastern Europe and Central Asia

The Global Epidemic (S Vermund, Section Editor)

Understanding HIV Compartments and Reservoirs

The Global Epidemic (S Vermund, Section Editor)

A Lifecycle Approach to HIV Prevention in African Women and Children

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.